Cryoport, Inc. (CYRX) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Cryoport’s revenue went from $8M in fiscal 2016 to $176M in fiscal 2025, growth of about 41.6% a year.
Net income in fiscal 2025 was $78M, a net margin of 44.4%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $192M and net income -$41M.
Free cash flow was -$25M in fiscal 2025 and positive in 0 of the 10 years shown.
The diluted share count rose 252% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $192M | $176M | $157M | $169M | $237M | $223M | $79M | $34M | $20M | $12M | $8M |
| Gross profit | $90M | $83M | $70M | $75M | $104M | $97M | $36M | $17M | $10M | $6M | $3M |
| Operating income | -$38M | -$37M | -$122M | -$101M | -$32M | -$18M | -$30M | -$18M | -$9M | -$8M | -$9M |
| Net income | -$41M | $78M | -$115M | -$100M | -$37M | -$276M | -$33M | -$18M | -$10M | -$8M | -$13M |
| EPS (diluted) | $-0.98 | $1.40 | $-2.49 | $-2.21 | $-0.93 | $-6.18 | $-1.94 | $-0.55 | $-0.34 | $-0.34 | $-0.93 |
| R&D | $18M | $17M | $18M | $18M | $16M | $17M | $9M | $4M | $2M | $1M | $598106 |
| Revenue growth | — | +12.4% | −7.0% | −28.9% | +6.6% | +182.9% | +131.8% | +72.9% | +64.2% | +55.7% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $11M | -$9M | -$16M | -$757000 | -$2M | $8M | -$15M | -$1M | -$3M | -$4M | -$6M |
| Capital spending | -$30M | -$16M | -$17M | -$39M | -$22M | -$24M | -$9M | -$5M | -$3M | -$2M | -$1M |
| Free cash flow | -$19M | -$25M | -$34M | -$40M | -$24M | -$16M | -$24M | -$7M | -$6M | -$5M | -$7M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | $10M | — | — | $38M | $0 | $0 | — | — | — | — |
| Stock-based pay | $10M | $10M | $17M | $20M | $20M | $15M | $9M | $17M | $5M | $4M | $3M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $411M | $251M | $446M | $516M | $629M | $93M | $94M | $47M | $15M | $5M |
| Debt | — | $44M | $51M | $36M | $29M | $23M | $129M | $5M | $17M | $0 | — |
| Equity | — | $503M | $402M | $489M | $556M | $642M | $383M | $126M | $39M | $18M | $6M |
| Total assets | — | $765M | $703M | $958M | $1.0B | $1.1B | $552M | $136M | $57M | $20M | $8M |
| Shares (diluted) | 51M | 50M | 49M | 49M | 49M | 46M | 39M | 33M | 28M | 23M | 14M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 46.9% | 47.1% | 44.4% | 44.7% | 43.8% | 43.4% | 46.2% | 51.1% | 52.2% | 49.9% | 40.4% |
| Operating margin | -20.0% | -20.9% | -77.6% | -59.6% | -13.5% | -8.0% | -38.1% | -52.1% | -44.0% | -66.0% | -114.2% |
| Net margin | -21.5% | 44.4% | -73.2% | -59.1% | -15.7% | -123.8% | -41.5% | -54.0% | -48.7% | -66.1% | -170.8% |
| FCF margin | -9.8% | -14.2% | -21.4% | -23.4% | -10.1% | -7.1% | -30.2% | -19.6% | -31.9% | -44.3% | -88.3% |
| ROIC | — | -5.3% | -21.2% | -15.1% | -4.3% | -2.1% | -5.9% | -10.7% | -12.3% | -34.9% | -121.9% |
| ROE | — | 15.6% | -28.5% | -20.4% | -6.7% | -42.9% | -8.5% | -14.5% | -24.8% | -44.2% | -230.8% |
Frequently asked questions
What is Cryoport’s annual revenue?
$176M in fiscal 2025 and $192M over the twelve months to September 30, 2026.
How much profit does Cryoport make?
Net income was $78M in fiscal 2025 (net margin 44.4%).
Is Cryoport’s revenue growing?
Yes: revenue rose 12.4% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.